Reading Time: < 1 minuteIntroduction Growth hormone (GH) deficiency, prevalent in approximately 1 in 4,000 American adult males, manifests with multisystemic sequelae including impaired hematopoiesis and coagulopathy. Saizen® (somatropin), a recombinant human GH analog, has been a cornerstone therapy for GH-deficient patients. This article …

